Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 07 05 2024] - (CGWL)
-
Net Asset Value(s)
-
Alliance Trust PLC - Net Asset Value
-
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
-
Statement by Ryan Donovan on Selection of Alanna McCargo as New FHLBank San Francisco President and CEO
-
Greystone Housing Impact Investors Reports First Quarter 2024 Financial Results
-
Blink Charging Launches New Preventative Maintenance Program, Blink Care
-
Update on Debt Funding
-
Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine
-
Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine
-
Foresight Leverages NVIDIA Jetson Orin to Introduce Novel 360-degree 3D Perception Solution
-
Beztak Recognized as a US Best Managed Company
-
Applied Digital Announces Upcoming Conference Participation
-
Payment of dividend
-
Alanna McCargo Named President and Chief Executive Officer of the Federal Home Loan Bank of San Francisco
-
Captura Advances to the Top 20 Finalists in XPRIZE Carbon Removal Competition
-
Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
-
First Merchants Corporation Announces Cash Dividend
-
Terra Balcanica Announces Proposed Share Consolidation and Engages Market Maker
-
United Way of Metropolitan Dallas Chooses SylogistMission
-
Optiva Awarded ISO 27001 Certification Demonstrating Commitment to Cybersecurity
-
Rakovina Therapeutics Announces Extensions and Expansions of Strategic Collaborations to Support AI Research
-
Puma Launches 2024 Exploration Program at Jonpol Gold
-
Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
-
Core Molding Technologies to Participate in the EF Hutton Annual Global Conference in NYC
-
TytoCare and Urgent Care Association to Host Major Health System Leaders for Rural & Urgent Care Clinic Virtual Summit
-
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
-
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
-
LGI Homes Announces its Second Community in the Modesto Market
-
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
-
Jewelry Franchisee The Michaels Group Chooses Clip for Secure, Cost-Effective Cash Management
-
StarTree Extends Real-Time Analytics Capabilities for Observability and Anomaly Detection Use Cases
-
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024
-
MEDIA ADVISORY: INTERVIEW OPPORTUNITIES
-
Fobi AI Partners with Verifiction to Enhance Data Verification and Cyber Security Protection
-
Horizon Aircraft Provides Update on Technical Flight Testing Progress
-
TSS, INC. TO REPORT FIRST QUARTER 2024 RESULTS ON TUESDAY, MAY 15th, 2024
-
SRAX Signs Agreement to Merge with DNA Holdings
-
HF Foods Reports First Quarter 2024 Financial Results
-
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
-
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
-
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock
-
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects
-
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
-
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
-
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
-
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
